Insider Transactions in Q2 2021 at Core Laboratories N V (CLB)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Gwendolyn Schreffler SVP |
SELL
Other acquisition or disposition
|
Direct |
2,896
-36.99%
|
-
|
|
Apr 01
2021
|
Gregory Barry Barnett Director |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.25%
|
$2,190
$30.1 P/Share
|
|
Apr 01
2021
|
Gregory Barry Barnett Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+32.84%
|
-
|
|
Apr 01
2021
|
Martha Z. Carnes Director |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.35%
|
$2,190
$30.1 P/Share
|
|
Apr 01
2021
|
Martha Z. Carnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+41.0%
|
-
|
|
Apr 01
2021
|
Harvey Robert Klingensmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.44%
|
$2,190
$30.1 P/Share
|
|
Apr 01
2021
|
Harvey Robert Klingensmith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+46.78%
|
-
|
|
Apr 01
2021
|
Michael Straughen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,746
-37.63%
|
$202,380
$30.1 P/Share
|
|
Apr 01
2021
|
Michael Straughen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+44.73%
|
-
|
|
Apr 01
2021
|
Eeuwijk Monique Van Dijken Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,181
-49.5%
|
$215,430
$30.1 P/Share
|
|
Apr 01
2021
|
Eeuwijk Monique Van Dijken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+50.0%
|
-
|
|
Apr 01
2021
|
Margaret Ann Van Kempen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,181
-35.9%
|
$215,430
$30.1 P/Share
|
|
Apr 01
2021
|
Margaret Ann Van Kempen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,507
+42.04%
|
-
|